1. Home
  2. OPK vs EMBC Comparison

OPK vs EMBC Comparison

Compare OPK & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • EMBC
  • Stock Information
  • Founded
  • OPK 2007
  • EMBC 1924
  • Country
  • OPK United States
  • EMBC United States
  • Employees
  • OPK N/A
  • EMBC N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • EMBC Medical/Dental Instruments
  • Sector
  • OPK Health Care
  • EMBC Health Care
  • Exchange
  • OPK Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • OPK 1.0B
  • EMBC 1.0B
  • IPO Year
  • OPK 1995
  • EMBC N/A
  • Fundamental
  • Price
  • OPK $1.68
  • EMBC $14.10
  • Analyst Decision
  • OPK Strong Buy
  • EMBC Buy
  • Analyst Count
  • OPK 3
  • EMBC 2
  • Target Price
  • OPK $2.75
  • EMBC $19.00
  • AVG Volume (30 Days)
  • OPK 2.8M
  • EMBC 441.4K
  • Earning Date
  • OPK 02-27-2025
  • EMBC 02-06-2025
  • Dividend Yield
  • OPK N/A
  • EMBC 4.25%
  • EPS Growth
  • OPK N/A
  • EMBC 2.96
  • EPS
  • OPK N/A
  • EMBC 0.99
  • Revenue
  • OPK $711,408,000.00
  • EMBC $1,107,700,000.00
  • Revenue This Year
  • OPK N/A
  • EMBC $0.26
  • Revenue Next Year
  • OPK $0.00
  • EMBC $1.24
  • P/E Ratio
  • OPK N/A
  • EMBC $14.24
  • Revenue Growth
  • OPK N/A
  • EMBC N/A
  • 52 Week Low
  • OPK $0.86
  • EMBC $9.93
  • 52 Week High
  • OPK $1.76
  • EMBC $21.48
  • Technical
  • Relative Strength Index (RSI)
  • OPK 62.47
  • EMBC 22.61
  • Support Level
  • OPK $1.60
  • EMBC $14.55
  • Resistance Level
  • OPK $1.68
  • EMBC $15.72
  • Average True Range (ATR)
  • OPK 0.06
  • EMBC 0.91
  • MACD
  • OPK 0.01
  • EMBC -0.33
  • Stochastic Oscillator
  • OPK 77.78
  • EMBC 6.28

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: